Droxidopa
- TRADE NAME: Northera (Chelsea Therapeutics)
- INDICATIONS: Neurogenic orthostatic hypotension
- SYNONYM: L-DOPS
- CLASS: Amino acid analog (synthetic)
- HALF-LIFE: 2.5 hours
FDA APPROVAL DATE: 02/18/2014
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:None known
PREGNANCY CATEGORY: C
SUPINE HYPERTENSION
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
NEUROMUSCULAR/SKELETAL.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric